https://www.selleckchem.com/pr....oducts/bozitinib.htm
Similar to the side effects of cancer treatment, financial toxicity (FT) can affect the quality of life of patients, which has attracted increasing attention in the field of oncology. Despite the fact that the estimated prevalence and risk factors of FT are widely reported, these results have not been synthesized. This review is aimed to systematically assess the prevalence and risk factors of self-reported FT. Systematic review and meta-analyses. A computer search of English literature was conducted using databases of PubMed, EMBASE,
Mi piace
Commento
Condividi
